iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/20176271
Asthma: clinical expression and molecular mechanisms - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb;125(2 Suppl 2):S95-102.
doi: 10.1016/j.jaci.2009.10.047.

Asthma: clinical expression and molecular mechanisms

Affiliations
Review

Asthma: clinical expression and molecular mechanisms

Robert F Lemanske Jr et al. J Allergy Clin Immunol. 2010 Feb.

Abstract

Asthma is a complex disorder that displays heterogeneity and variability in its clinical expression both acutely and chronically. This heterogeneity is influenced by multiple factors including age, sex, socioeconomic status, race and/or ethnicity, and gene by environment interactions. Presently, no precise physiologic, immunologic, or histologic characteristics can be used to definitively make a diagnosis of asthma, and therefore the diagnosis is often made on a clinical basis related to symptom patterns (airways obstruction and hyperresponsiveness) and responses to therapy (partial or complete reversibility) over time. Although current treatment modalities are capable of producing control of symptoms and improvements in pulmonary function in the majority of patients, acute and often severe exacerbations still occur and contribute significantly to both the morbidity and mortality of asthma in all age groups. This review will highlight some of the important clinical features of asthma and emphasize recent advances in both pathophysiology and treatment.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Inflammatory and remodeling responses in asthma with activation of the epithelial mesenchymal trophic unit. The epithelial mesenchymal trophic unit has been defined as bidirectional interaction between the epithelium and underlying mesenchyme involving the release of selective growth factors and cytokines. Epithelial damage alters the set point for communication between bronchial epithelium and underlying mesenchymal cells, leading to myofibroblast activation, an increase in mesenchymal volume, and induction of structural changes throughout airway wall.

Similar articles

Cited by

References

    1. Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178:667–672. - PMC - PubMed
    1. Kusel M.M., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119:1105–1110. - PMC - PubMed
    1. Bush R.K., Peden D.B. Advances in environmental and occupational disorders in 2008. J Allergy Clin Immunol. 2009;123:575–578. - PubMed
    1. Busse W.W., Lemanske R.F., Jr. Expert panel report 3: moving forward to improve asthma care. J Allergy Clin Immunol. 2007;120:1012–1014. - PubMed
    1. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B., et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47. - PubMed

Publication types

Substances